They're not secretly subsidizing, they're openly subsidizing.
Token pricing was a small minority of customers up until this year, when all the labs started trying to force customers onto token-based billing. Within the last week, Anthropic repriced my team's plan from a temporary "50% extra tokens" to 25%: <a href="https://support.claude.com/en/articles/15910845-claude-code-may-august-2026-weekly-limits-promotion" rel="nofollow">https://support.claude.com/en/articles/15910845-claude-code-...
The fact that all this is ongoing within such a short timeframe should make you suspicious of any analysis that claims to be observing "statistical trends" like they've discovered a new Moore's Law out of 6 months of pricing data from 2 companies.
your repricing has nothing to do with subsidising which means selling at a loss. Within this year, the real prices have gone down more than 10x on average which is way more than the teeny 25% you are fighting for.
simianwords · · focus · HN ↗
Then we have these articles that say tokens will get so cheap that labs won’t know how to make profit.
Who is correct?
jackb4040 · · focus · HN ↗
Token pricing was a small minority of customers up until this year, when all the labs started trying to force customers onto token-based billing. Within the last week, Anthropic repriced my team's plan from a temporary "50% extra tokens" to 25%: <a href="https://support.claude.com/en/articles/15910845-claude-code-may-august-2026-weekly-limits-promotion" rel="nofollow">https://support.claude.com/en/articles/15910845-claude-code-...
The fact that all this is ongoing within such a short timeframe should make you suspicious of any analysis that claims to be observing "statistical trends" like they've discovered a new Moore's Law out of 6 months of pricing data from 2 companies.
simianwords · · focus · HN ↗